Adult Stem Cell Doc Blog

Cell reprogramming calls The Curious Case of Benjamin Button to mind. It's a new technology that uses molecular therapy to coax adult cells to revert to an embryonic stem cell-like state, allowing scientists to later re-differentiate these cells into specific types with the potential to treat heart attacks or diseases such as Parkinson's...

Tarix Pharmaceuticals announced that it's drug, TXA127, has been granted Orphan Drug designation from the U.S. Food and Drug Administration (FDA) as a treatment to enhance engraftment in patients receiving a stem cell transplant. TXA127 has also received Orphan Drug designation for the treatment of Myelodysplastic Syndrome (MDS)...

New research from Japan suggests that dental pulp from extracted teeth may be an easy source of Induced Pluripotent Stem (IPS) cells, which like embryonic stem cells, have the potential to form several different cell types, but without the controversial ethical problems. These were the findings of a study led by K...